Highlights
- Professor Caroline Gargett leads groundbreaking research using menstrual fluid for non-invasive endometriosis diagnosis.
- The Australian Menstrual Fluid Biobank for Endometriosis Research (AMBER) aims to shorten diagnostic delays and advance treatment personalization.
- Gargett’s research supported by international funding highlights the potential for innovative diagnostics and therapeutic strategies.
Professor Caroline Gargett, a recognized leader in endometriosis research, is pioneering a non-invasive diagnostic technique using menstrual fluid. This method, which is currently under development, aims to dramatically reduce the time taken to diagnose endometriosis, a condition that significantly affects women’s quality of life. Her efforts have led to the creation of the Australian Menstrual Fluid Biobank for Endometriosis Research (AMBER), which stores various components of menstrual fluid for research purposes.
The biobank is instrumental in developing new diagnostics and treatments for endometriosis, potentially revolutionizing how the disease is managed. It enables the analysis of menstrual fluid samples with the same regularity as blood tests, moving towards more personalized treatment approaches. This includes the creation of 3D endometrial organoids and stromal cultures from biobank samples, which can be used to tailor treatments to individual patients.
Professor Gargett’s innovative work, which has garnered international support including a significant grant from the United States Department of Defense, illustrates the profound impact of combining scientific research with practical healthcare solutions to address chronic health issues affecting millions of women globally.
About the Author
Biobanking.com delivers valuable news and information on biobanking, biorepositories, cryopreservation, and biosample/biospecimen management, while connects buyers with top vendors globally.
